| [1] |
. Curr Med Res Opin，2011，27（8）：1635-1643.
|
| [2] |
Bhatt JM，Lin HW，Bhattacharyya N. Prevalence，severity，exposures，and treatment patterns of tinnitus in the United States［J］. JAMA Otolaryngol Head Neck Surg，2016，142（10）：959-965.
|
| [3] |
Galazyuk A，Brozoski TJ. Animal models of tinnitus：a review［J］. Otolaryngol Clin North Am，2020，53（4）：469-480.
|
| [4] |
Li SH，Han DY，Yang WY，et al. Research progress on the ototoxicity mechanism of sodium salicylate［J］. J Audiol Speech Pathol（听力学及言语疾病杂志），2001，9（3）：174-176.
|
| [5] |
Steffens DC，Wei Jiang，Krishnan KR，et al. Metabolomic differences in heart failure patients with and without major depression［J］. J Geriatr Psychiatry Neurol，2010，23（2）：138-146.
|
| [6] |
Li WW，Yang Y，Wang SC，et al. Research progress of cellular metabolomics［J］. J Nanjing Univ Tradit Chin Med（南京中医药大学学报），2017，33（2）：187-192.
|
| [7] |
Lu Z，Li S，Sun R，et al. Hirsutella sinensis treatment shows protective effects on renal injury and metabolic modulation in db/db mice［J］. Evid Based Complement Alternat Med，2019，2019：4732858.
|
| [8] |
Wang W，Cai Q，Zhou F，et al. Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction［J］. Redox Biol，2018，15：253-265.
|
| [9] |
McEvilly M，Popelas C，Tremmel B. Use of uridine triacetate for the management of fluorouracil overdose［J］. Am J Health Syst Pharm，2011，68（19）：1806-1809.
|
| [10] |
Gallai V，Mazzotta G，Montesi S，et al. Effects of uridine in the treatment of diabetic neuropathy：an electrophysiological study［J］. Acta Neurol Scand，1992，86（1）：3-7.
|
| [11] |
Mironova GD，Khrenov MO，Talanov EY，et al. The role of mitochondrial KATP channel in anti-inflammatory effects of uridine in endotoxemic mice［J］. Arch Biochem Biophys，2018，654：70-76.
|
| [12] |
Le TT，Ziemba A，Urasaki Y，et al. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation［J］. J Lipid Res，2013，54（4）：1044-1057.
|
| [13] |
Sun Q. Glutamate excitotoxicity and the effect of glutamate-glutamine cycle in the cochlea （耳蜗谷氨酸兴奋性毒性及谷氨酸—谷氨酰胺循环机制的研究）［D］. Beijing：PLA Postgraduate Medical School，2004.
|
| [14] |
Fuhrman S，Palkovits M，Cassidy M，et al. The regional distribution of N-acetylaspartylglutamate （NAAG） and peptidase activity against NAAG in the rat nervous system［J］. J Neurochem，1994，62（1）：275-281.
|
| [15] |
Zhao J，Ramadan E，Cappiello M，et al. NAAG inhibits KCl-induced［3H］-GABA release via mGluR3，cAMP，PKA and L-type calcium conductance［J］. Eur J Neurosci，2001，13（2）：340-346.
|
| [16] |
Sanabria ER，Wozniak KM，Slusher BS，et al. GCP II （NAALADase） inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism［J］. J Neurophysiol，2004，91（1）：182-193.
|
| [17] |
Romei C，Raiteri M，Raiteri L. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate （NAAG）［J］. Neuropharmacology，2013，66：311-316.
|
| [18] |
Fulop T，Radabaugh S，Smith C. Activity-dependent differential transmitter release in mouse adrenal chromaffin cells［J］. J Neurosci，2005，25（32）：7324-7332.
|
下载:
